Glucagon-like peptide-1 receptor agonists, also known as GLP-1 analogs, GLP-1RAs, or incretin mimetics, are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. From Wikipedia
A novel peptide–antibody conjugate demonstrates additive weight loss effects by simultaneously activating GIPR and GLP-1R in the brain.
